Fulcrum Therapeutics Inc (NASDAQ:FULC)

5.15
Delayed Data
As of Jun 24
 +0.04 / +0.78%
Today’s Change
3.21
Today|||52-Week Range
33.10
-70.89%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Gould Robert J
Director
Sale4/05/202252,552$24.26$1.3M-78.47%
Gould Robert J
Director
Sale4/01/202234,464$24.03$828.2K-78.35%
Stuart Bryan E
Director
Sale8/11/202128,000$23.75$665.0K-74.55%
Gould Robert J
Director
Sale6/07/202271,435$8.09$577.9K-36.23%
Gould Robert J
Director
Buy6/07/202271,435$7.84$560.1K-36.23%
Stuart Bryan E
Director
Sale8/10/202132,000$17.50$560.0K-72.62%
Moxham Christopher
Chief Scientific Officer
Sale8/10/202131,071$18.00$559.3K-72.62%
Gould Robert J
Director
Buy4/05/202252,552$7.84$412.0K-78.47%
Moxham Christopher
Chief Scientific Officer
Sale8/10/202120,714$17.00$352.1K-72.62%
Gould Robert J
Director
Buy4/01/202234,464$7.84$270.2K-78.35%
Page of 3